| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy. | Cytotherapy | 2003 | 1.18 |
| 2 | Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells. | Leukemia | 2006 | 1.12 |
| 3 | The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. | Gene Ther | 2011 | 1.09 |
| 4 | Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype. | Leukemia | 2010 | 0.89 |
| 5 | PET imaging of T cells derived from umbilical cord blood. | Leukemia | 2008 | 0.88 |
| 6 | Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials. | Cytotherapy | 2007 | 0.84 |